Xeris Biopharma director John Johnson sells $91,422 in shares

Created at 5 Jun · 22:51 UTC2 sources2 events

IN SHORT

Xeris Biopharma director John Johnson sold 91,422 shares of the company's stock, valued at $91,422. The transaction was disclosed in a recent SEC filing.

Key Numbers

91,422 sharesshares sold by director

$91,422value of shares sold by director

Who's Involved

John Johnson

Director at Xeris Biopharma who sold shares

Xeris Biopharma

Company whose director sold shares

Key facts

Xeris Biopharma director John Johnson sold shares.
The value of the shares sold was $91,422.
The sale involved 91,422 shares.
The transaction was disclosed in a recent SEC filing.

Xeris Biopharma director John Johnson has sold 91,422 shares of the company's stock. The total value of this transaction amounts to $91,422. This insider trading activity was recently disclosed in a filing with the U.S. Securities and Exchange Commission (SEC).

↳ Why This Matters

Insider selling can sometimes signal a lack of confidence from company executives, potentially impacting investor sentiment.

FREQUENTLY ASKED

John Johnson is a director at Xeris Biopharma.

He sold 91,422 shares of Xeris Biopharma stock valued at $91,422.

The sale was disclosed in a recent SEC filing.

What Happens Next

01Further SEC filings will disclose any additional insider transactions.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

CME Headlines

Xeris Biopharma director John Johnson sells $91,422 in shares

PiQ Daily

Key facts

Get the newsletter.

Xeris Biopharma director John Johnson sells $91,422 in shares

PiQ Daily

Key facts

Get the newsletter.